US Stock MarketDetailed Quotes

OCX OncoCyte

Watchlist
  • 2.9000
  • -0.1000-3.33%
Trading Nov 4 15:12 ET
48.82MMarket Cap-683P/E (TTM)

About OncoCyte Company

OncoCyte Corp. is a molecular diagnostics company, which engages in the development and commercialization of diagnostic tests for the detection of cancer, including molecular diagnostic services to pharmaceutical customers. Its products include DetermaRx and DetermaIO. The firm also offers pharmaceutical services like multi-analyte test development and clinical trial services. The company was founded in September 2009 and is headquartered in Alameda, CA.

Company Profile

SymbolOCX
Company NameOncoCyte
Listing DateJan 6, 2016
Issue Price6.25
Founded2009
CEOMr. Joshua Riggs
MarketNASDAQ
Employees46
Fiscal Year Ends12-31
Address15 Cushing
CityIrvine
ProvinceCalifornia
CountryUnited States of America
Zip Code92618
Phone1-949-409-7600
Websitehttp://www.oncocyte.com

Company Executives

  • Name
  • Position
  • Salary
  • Joshua Riggs
  • Director, President and Chief Executive Officer
  • 724.91K
  • Ekkehard Schutz, M.D.,PhD
  • Chief Science Officer
  • 575.17K
  • Andrea James
  • Chief Financial Officer
  • --
  • James Liu
  • Senior Director, Controller and Principal Accounting Officer
  • 304.51K
  • Andrew Arno
  • Chairman of the Board
  • 112.54K
  • Louis E. Silverman
  • Lead Independent Director
  • 97.70K
  • Dr. Andrew J. Last, PhD
  • Independent Director
  • 92.86K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data